Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures

OBJECTIVE: Lusutrombopag is a thrombopoietin receptor agonist that improves thrombocytopenia in patients with chronic liver disease scheduled to undergo invasive procedures. However, information on the efficacy of repeated lusutrombopag treatment and factors associated with the treatment is scarce....

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Yuno, Kawaoka, Tomokazu, Imamura, Michio, Namba, Maiko, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ohya, Kazuki, Daijo, Kana, Teraoka, Yuji, Morio, Kei, Fujino, Hatsue, Nakahara, Takashi, Yamauchi, Masami, Hiramatsu, Akira, Tsuge, Masataka, Aikata, Hiroshi, Takahashi, Shoichi, Hayes, C. Nelson, Fukuhara, Takayuki, Tsuji, Keiji, Arataki, Keiko, Nagaoki, Yuko, Aisaka, Yasuyuki, Kamada, Koji, Kodama, Hideaki, Chayama, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024946/
https://www.ncbi.nlm.nih.gov/pubmed/33087674
http://dx.doi.org/10.2169/internalmedicine.5930-20

Ejemplares similares

Ejemplares similares